Stephen Schoenberger

• Validating T cell responses from blood to reduce target selection risk and eliminate non-functional epitopes from manufacturing

• Mapping TCR dynamics longitudinally to guide dosing decisions and build confidence in immune activity before clinical endpoints

• Pairing bioinformatics with functional immunology to prove the mechanism of action and support regulatory acceptance of personalized therapies

• Using early immune analytics to de-risk trial failure and accelerate iteration across both vaccine design and manufacturing batches